Apollomics, Inc. Company Operational Continuity Update
October 13, 2025 21:22 ET | Source: Apollomics Inc. FOSTER CITY, Calif.,…
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre”…
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most…
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
ANDERNACH, Germany, Oct. 13, 2025 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"),…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:…
36-Year-Old Man Given a Second Chance at Life With Advanced Heart Pump
INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old…
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global…
HomeInherit Introduces Investment Model Offering Seniors Liquidity Without Leaving Their Homes
HomeInherit Logo NEW YORK, Oct. 11, 2025 (GLOBE NEWSWIRE) -- HomeInherit today…
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…